HBP BRAVE Partner project - Open Workshop

The BRAVE project addresses the problem of COVID-19's impact on the brain by tackling COVID-19 brain inflammation by computer-aided molecular design. The aim of the project is to block SARS-CoV-2 mediated neurodegeneration and brain damage by inhibiting the activation of the NLRP3 inflammasome, which is responsible for neuroinflammation in several neurodegenerative conditions such as Alzheimer's disease and long COVID-19. The results of this project will be presented and discussed in this workshop.